AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

PREGABALIN 50 Mg ;

9 registrations across 1 African market— 9 active

Markets with PREGABALIN 50 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Hexgabalin 50mg
Hard Gelatin Capsules
🇪🇬EgyptGlobal NAPI Pharmaceuticals - GNPactive
Myafibrol 50 mg
Hard Gelatin Capsules
🇪🇬Egyptrotabiogen for Pharmaceutical Investments and Chemicalsactive
Depapalin 50 mg
Hard Gelatin Capsules
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
Hexgabalin 50mg
Hard Gelatin Capsules
🇪🇬EgyptGlobal NAPI Pharmaceuticals - GNPactive
Lyrica® 50mg
Hard Gelatin Capsules
🇪🇬EgyptViatris Egyptactive
Pregaba 50 mg
Hard Gelatin Capsules
🇪🇬EgyptEgyptian Group for Pharmaceutical Industries - EGPIactive
Myafibrol 50 mg
Hard Gelatin Capsules
🇪🇬Egyptrotabiogen for Pharmaceutical Investments and Chemicalsactive
Depapalin 50 mg
Hard Gelatin Capsules
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
Pregaba 50 mg
Hard Gelatin Capsules
🇪🇬EgyptEgyptian Group for Pharmaceutical Industries - EGPIactive

PREGABALIN 50 Mg ; in Africa — Regulatory Overview

PREGABALIN 50 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.